entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
401431,ATP6V0E2-AS1,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,113.698085732195,0.0387686616078645,0.191589069339956,0.202353201784562,0.839640611105581,0.964890184102308,NA
401431,ATP6V0E2-AS1,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,192.057321740782,-0.246401291827804,0.134815090860009,-1.82769814755876,0.0675948663167083,0.339301495402344,patient-derived GBM cell lines (PDGCLs)
401431,ATP6V0E2-AS1,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,46.8549244135327,-1.05947795921088,0.313041512274869,-3.38446473603985,0.000713171792608542,0.00512108467938239,A549
401431,ATP6V0E2-AS1,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,50.8676641823504,-0.41941308402408,0.282096761144416,-1.48677029230182,0.137075490243042,0.87247654797719,A549
401431,ATP6V0E2-AS1,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,38.4697453023324,-0.374002699620379,0.486068338058443,-0.769444685729377,0.441629369704294,0.772896201133837,A549
401431,ATP6V0E2-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,15.5197470061893,0.23575208118597,0.667458342419702,0.353208681655413,0.723931999804835,1,sigmoid colon organoid
401431,ATP6V0E2-AS1,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,15.5197470061893,0.382369421847234,0.663244722207359,0.576513327651763,0.564268264055663,1,sigmoid colon organoid
